期刊文献+

α-硫辛酸联合复荣通脉胶囊治疗糖尿病周围神经病变疗效观察 被引量:7

Clinical observation on treating diabetic peripheral neuropathy with α-lipoic acid plus Furong Tongmai capsule
下载PDF
导出
摘要 观察α-硫辛酸联合复荣通脉胶囊治疗糖尿病周围神经病变的临床疗效。60例患者随机分为治疗组和对照组,两组均给予常规治疗,对照组予复荣通脉胶囊,治疗组在对照组基础上加用α-硫辛酸600mg。α-硫辛酸联合复荣通脉胶囊均能明显改善糖尿病周围神经病变患者的临床症状,两者联合应用较单独应用复荣通脉胶囊疗效更好。 To observe clinical efficacy ofα-lipoic acid plus Furong Tongmai capsule on diabetic peripheral neuropathy. 60 patients were randomly divided into the treatment group and the control group, all patients were given conventional therapy, the control was given Furong Tongmai capsule, the treatment was treated by α-lipoic acid plus Furong Tongmai capsule. α-lipoic acid plus Furong Tongmai capsule can improve clinical symptoms, it was effective on diabetic peripheral neuropathy.
出处 《中医临床研究》 2014年第17期49-50,共2页 Clinical Journal Of Chinese Medicine
关键词 Α-硫辛酸 糖尿病周围神经病变 疗效观察 α-lipoic acid Diabetic peripheral neuropathy Clinical observation
  • 相关文献

参考文献4

二级参考文献21

  • 1蒋雯巍,蒋雨平.高同型半胱氨酸血症与糖尿病神经病变[J].中华老年医学杂志,2005,24(9):708-708. 被引量:14
  • 2李玫玫.糖尿病神经病变[J].医学综述,2006,12(16):997-998. 被引量:25
  • 3王金树,卢爱萍.糖尿病神经病变相关因素分析[J].实用临床医学(江西),2006,7(10):46-48. 被引量:18
  • 4宁光.糖尿病周围神经病变诊断研究进展[J].中国实用内科杂志,2007,27(7):487-489. 被引量:71
  • 5蒋国秀.实用糖尿病学[M].北京:人民卫生出版社,1992..
  • 6Singh NP,Pgyazhendhi V,Das AK,et al.Clinical and laboratory profile of diabetes in elderly[J].Indian Med Assoc,1997,97(6):124-128.
  • 7Akbar DH,Mira SA,Zawawi TH,et al.Subclincal diabetes neuropathy:a common complication in Saudi diabetes[J].Saudi Med,2000,21(5):433-437.
  • 8Collin HL,Niskanen L,Unsitupa M,et al.Oral symptoms and sign in elderly.Patients with type 2 diabetes mellitus[J].Oral Surg Med Oral Pathol Oral Radiol Endod,2000,90(3):299-305.
  • 9Greene DA,Sima AAF,Stevens MJ,et al.Complications:Neuropathy,Pathogenetic consideration[J].Diabetes Care,1992,15(12):1902-1904.
  • 10Flynn MD,Tooke JE.Diabetic neuropathy and the microcirculation[J].Diabet Md,1995,12(4):298-300.

共引文献42

同被引文献46

  • 1李玫玫.糖尿病神经病变[J].医学综述,2006,12(16):997-998. 被引量:25
  • 2陈灏珠.实用内科学.第12版.北京:人民卫生出版社,2005,1469-1471.
  • 3Stevens MJ, Obrosova I, Cao X, et al. Effects of DL-alpha-lipoic acid on peripheral nerve conduc- tion, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy[J]. Dia- betes,2000,49(6) :1006--1015.
  • 4ShakherJ, StevensMJ. Update on the management of dia- betic polyneuropathies ~J]. Diabetes Metab S~ndr Obes, 2011, 4(1 ):289-305.
  • 5Feldman EL. Oxidative stress and diabetic neuropathy:a new understanding of an old problem ~J]. JClinlnvest, 2003, 111 (4):431 -433.
  • 6Stevens MJ, Obrosoval I, Cao X, et al. Effects of DL-al- pha-lipoic acid onperipheral nerve conduction, blood flow, energy metabolism, and oxidation stress in experimental diabetic neuropathy E J ].Diabetes,2000,49:1006.
  • 7Ametov AS, Barinov A, Dyck P J, et al. The sensory syrup toms of diabetic polyneuropathy are improved with alph-alipoicacid: the SYDNEY trial [J3. Diabetes Care, 2003, 26. 770-776.
  • 8Brown lee M. Biochemistry and molecular cell biology of diabeticcomplications [ J 3.Nature, 2001, 414 (5): 813-820.
  • 9van Dam PS. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives [J]. Diabetes Metab ResRev, 2002,18(3):176-184.
  • 10Lal MA, KomerA, MatsuoY, et al. Combined antioxidant and COMT inhibitor treatment reverses renal abnorinali- ties in diabetic ratsIJl. Diabetes, 2000, 49:1381-1389.

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部